Indoco Remedies has informed the exchanges that it has received approval from the UK regulatory body UK Medicines and Healthcare products Regulatory Agency, for its solid dosages manufacturing facility at Goa (Plant I). This approval follows the inspection conducted in December 2016. The company is a fully integrated, research-oriented pharma company engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients. After surging to a high of ₹249.80 on the NSE in earlier trades in the day, shares of Indoco Remedies closed ₹4.95 lower vis-à-vis the previous day’s close at ₹225 on the NSE.

Gravita India has informed the exchanges that its engineering and lead recycling turnkey solutions arm has received orders worth ₹15 crore from Metal Lead Factory for Metals Casting and Quiwan Group from the Middle East. The orders will be executed by the end of December 2017. The company further said the order is from independent international parties and the promoters or promoter group companies have no interest in the entities providing the order. Shares of Gravita hit a year high of ₹74.95 before closing at ₹72.75, a gain of 1.6 per cent, on the NSE.

Ujaas Energy has been awarded an additional allocation order of 2,500Kwp grid connected SPV power plants under the ‘Rooftop Solar Power Generation Scheme 2015-16’ in Rajasthan. Also, of all the other bidders in the first allotment, UJAAS is the only company to be awarded an additional allocation order. Shares of Ujaas Energy slipped 1.22 per cent at ₹36.30 on the NSE.

Related Topics
comment COMMENT NOW